Literature DB >> 34987738

CNS Post-Transplant Lymphoproliferative Disorder in a Heart Recipient: A Case Report.

A Amin1, M Chenaghlou2, E Zare3, N Naderi1, S Taghavi1.   

Abstract

Solid organ recipients have increased risk of malignancy in comparison with general population. Although post-transplant lymphoproliferative disorders are the second most common cancer in transplanted patients, primary CNS lymphoma is a rare presentation of these disorders. Among the wide range of neurologic complications in post- transplant period, some characteristics could be helpful for diagnosing of this disorder. Rarity of CNS lymphoma may lead to late diagnosis of this disease while early detection has utmost importance for better management of it. Here, we describe a heart recipient young woman with focal neurologic symptoms 14 months after transplantation and some features that could be helpful for on-time diagnosis.

Entities:  

Keywords:  CNS; Heart transplant; Lymphoma

Year:  2021        PMID: 34987738      PMCID: PMC8717963     

Source DB:  PubMed          Journal:  Int J Organ Transplant Med        ISSN: 2008-6482


  8 in total

1.  Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.

Authors:  Gayathri Kumarasinghe; Orly Lavee; Andrew Parker; Ian Nivison-Smith; Samuel Milliken; Anthony Dodds; Joanne Joseph; Keith Fay; David D Ma; Monique Malouf; Marshall Plit; Adrian Havryk; Ann M Keogh; Christopher S Hayward; Eugene Kotlyar; Andrew Jabbour; Allan R Glanville; Peter S Macdonald; John J Moore
Journal:  J Heart Lung Transplant       Date:  2015-06-11       Impact factor: 10.247

2.  Cerebral complications of solid organ transplantation.

Authors:  R Sonneville; E Mariotte; M C Brouwer
Journal:  Intensive Care Med       Date:  2019-01-30       Impact factor: 17.440

Review 3.  Malignancies: pre and post transplantation strategies.

Authors:  Meteb AlBugami; Bryce Kiberd
Journal:  Transplant Rev (Orlando)       Date:  2013-12-13       Impact factor: 3.943

4.  Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.

Authors:  Robert Cavaliere; Gina Petroni; Maria B Lopes; David Schiff
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

5.  Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.

Authors:  Genevieve M Crane; Helen Powell; Rumen Kostadinov; Patrick Tim Rocafort; Dena E Rifkin; Peter C Burger; Richard F Ambinder; Lode J Swinnen; Michael J Borowitz; Amy S Duffield
Journal:  Oncotarget       Date:  2015-10-20

6.  A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature.

Authors:  Anju John John Velvet; Shiv Bhutani; Stavros Papachristos; Reena Dwivedi; Michael Picton; Titus Augustine; Muir Morton
Journal:  Oncotarget       Date:  2019-01-11

Review 7.  Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential.

Authors:  Matthew L White; Drew W Moore; Yan Zhang; Keiper D Mark; Timothy C Greiner; Philip J Bierman
Journal:  Insights Imaging       Date:  2019-04-11

8.  Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation: Pathogenesis, Clinical Manifestations, Diagnosis, and Management.

Authors:  Marieke L Nijland; Marie José Kersten; Steven T Pals; Frederike J Bemelman; Ineke J M Ten Berge
Journal:  Transplant Direct       Date:  2015-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.